Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1963 1
1964 1
1966 1
1967 3
1968 3
1969 1
1970 5
1971 1
1972 3
1973 3
1975 3
1977 5
1978 5
1979 6
1980 8
1981 4
1982 6
1983 7
1984 4
1985 5
1986 5
1987 6
1988 7
1989 6
1990 11
1991 6
1992 12
1993 8
1994 8
1995 10
1996 18
1997 19
1998 11
1999 8
2000 8
2001 5
2002 9
2004 4
2005 7
2006 2
2007 6
2008 5
2009 1
2010 1
2011 1
2012 5
2013 1
2014 7
2015 6
2016 12
2017 5
2018 4
2019 3
2020 7
2021 5
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

312 results
Results by year
Filters applied: . Clear all
Page 1
P-TEFb as A Promising Therapeutic Target.
Fujinaga K. Fujinaga K. Molecules. 2020 Feb 14;25(4):838. doi: 10.3390/molecules25040838. Molecules. 2020. PMID: 32075058 Free PMC article. Review.
Molecular mechanisms of HIV latency.
Cary DC, Fujinaga K, Peterlin BM. Cary DC, et al. Among authors: fujinaga k. J Clin Invest. 2016 Feb;126(2):448-54. doi: 10.1172/JCI80565. Epub 2016 Jan 5. J Clin Invest. 2016. PMID: 26731470 Free PMC article. Review.
[Site-directed mutagenesis by PCR].
Yamashita T, Nishikawa T, Kawamura M, Fujinaga K. Yamashita T, et al. Among authors: fujinaga k. Tanpakushitsu Kakusan Koso. 1996 Apr;41(5):534-8. Tanpakushitsu Kakusan Koso. 1996. PMID: 8650336 Review. Japanese. No abstract available.
HEXIM1-Tat chimera inhibits HIV-1 replication.
Leoz M, Kukanja P, Luo Z, Huang F, Cary DC, Peterlin BM, Fujinaga K. Leoz M, et al. Among authors: fujinaga k. PLoS Pathog. 2018 Nov 5;14(11):e1007402. doi: 10.1371/journal.ppat.1007402. eCollection 2018 Nov. PLoS Pathog. 2018. PMID: 30395647 Free PMC article.
[Adenovirus].
Fujinaga K. Fujinaga K. Tanpakushitsu Kakusan Koso. 1982;27(16):2415-9. Tanpakushitsu Kakusan Koso. 1982. PMID: 7163512 Japanese. No abstract available.
The two sides of Tat.
Barboric M, Fujinaga K. Barboric M, et al. Among authors: fujinaga k. Elife. 2016 Jan 19;5:e12686. doi: 10.7554/eLife.12686. Elife. 2016. PMID: 26783762 Free PMC article.
[PCR machine].
Kimura S, Fujinaga K, Sekiya T. Kimura S, et al. Among authors: fujinaga k. Tanpakushitsu Kakusan Koso. 1996 Apr;41(5):514-7. Tanpakushitsu Kakusan Koso. 1996. PMID: 8650332 Review. Japanese. No abstract available.
New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis.
Shinohara S, Takahashi Y, Komuro H, Matsui T, Sugita Y, Demachi-Okamura A, Muraoka D, Takahara H, Nakada T, Sakakura N, Masago K, Miyai M, Nishida R, Shomura S, Shigematsu Y, Hatooka S, Sasano H, Watanabe F, Adachi K, Fujinaga K, Kaneda S, Takao M, Ohtsuka T, Yamaguchi R, Kuroda H, Matsushita H. Shinohara S, et al. Among authors: fujinaga k. J Immunother Cancer. 2022 Apr;10(4):e003765. doi: 10.1136/jitc-2021-003765. J Immunother Cancer. 2022. PMID: 35396225 Free PMC article.
312 results